CBPD-268

• Target :

  PROTACs|||Histone Acetyltransferase

• Related Pathways :

  Chromatin/Epigenetic|||PROTAC

• Bioactivity :

  CBPD-268 is an effective orally active CBP/p300 PROTAC degrader, with a DC50 value of ? 0.03 nM. It induces degradation of CBP/p300 and inhibits cell growth, exhibiting antitumor activity. Additionally, CBPD-268 shows potential for research in AR-positive prostate cancer.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C